granted
on 27 Jun 2024
Last Applicant/ Owned by
80 W. Lancaster Avenue, Suite 300
Devon
PA
19333
Serial Number
97235095 filed on 24th Jan 2022
Registration Number
N/A
Correspondent Address
Sarah Anne Keefe
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and Read More
Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech disorders and diseases, traumatic brain injury, and viral diseases and disorders; Pharmaceutical preparations for the treatment of fragile x syndrome, substance related addiction, autism and autism spectrum disorders, epilepsy, seizure diseases and disorders, anxiety, aphasias, stuttering, post-traumatic stress disorder; all of the foregoing specifically excluding narcolepsy and management of sleep disorders
N/A
N/A
No 97235095
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
27th Jun 2024 | SOU EXTENSION 3 FILED |
27th Jun 2024 | SOU EXTENSION 3 GRANTED |
27th Jun 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
27th Jun 2024 | SOU TEAS EXTENSION RECEIVED |
03rd Feb 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
01st Feb 2024 | SOU EXTENSION 2 GRANTED |
01st Feb 2024 | SOU EXTENSION 2 FILED |
01st Feb 2024 | SOU TEAS EXTENSION RECEIVED |
08th Jul 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
06th Jul 2023 | SOU EXTENSION 1 GRANTED |